The University of Chicago Header Logo

Michael Charlton

Concepts (760)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Liver Transplantation
126
2023
1271
20.320
Why?
Non-alcoholic Fatty Liver Disease
50
2024
212
10.650
Why?
Liver Cirrhosis
57
2024
300
10.630
Why?
Hepatitis C
49
2023
210
10.100
Why?
Hepatitis C, Chronic
38
2023
126
8.790
Why?
Fatty Liver
36
2023
125
7.800
Why?
Antiviral Agents
42
2023
512
7.540
Why?
Liver
47
2024
1229
5.500
Why?
Carcinoma, Hepatocellular
19
2023
386
5.110
Why?
Liver Neoplasms
21
2023
736
4.430
Why?
Hepacivirus
36
2023
160
4.080
Why?
End Stage Liver Disease
12
2023
62
3.550
Why?
Graft Survival
27
2022
885
3.230
Why?
Ribavirin
18
2023
58
2.890
Why?
Metabolic Syndrome
9
2019
142
2.780
Why?
Immunosuppressive Agents
19
2018
977
2.770
Why?
Graft Rejection
25
2019
1065
2.710
Why?
Obesity
20
2023
964
2.660
Why?
Liver Diseases, Alcoholic
6
2023
24
2.640
Why?
Tissue Donors
13
2022
465
2.610
Why?
Insulin Resistance
12
2023
377
2.570
Why?
Interleukins
7
2013
134
2.570
Why?
Liver Failure
14
2017
79
2.370
Why?
Humans
247
2024
86656
2.310
Why?
Recurrence
34
2019
1139
1.860
Why?
Male
136
2021
40995
1.760
Why?
Cardiovascular Diseases
9
2017
827
1.690
Why?
Hepatitis E
4
2015
9
1.690
Why?
Female
133
2021
44566
1.650
Why?
Viremia
7
2022
55
1.650
Why?
Middle Aged
106
2021
25027
1.620
Why?
Postoperative Complications
23
2018
2204
1.530
Why?
Sofosbuvir
10
2023
18
1.490
Why?
Liver Diseases
8
2021
239
1.480
Why?
Risk Factors
39
2022
5416
1.460
Why?
Adult
92
2024
25648
1.450
Why?
Treatment Outcome
47
2024
7982
1.450
Why?
RNA, Viral
20
2021
330
1.330
Why?
Uridine Monophosphate
5
2016
9
1.330
Why?
Interferon-alpha
10
2015
234
1.290
Why?
Sirolimus
3
2013
170
1.230
Why?
Tacrolimus
5
2017
373
1.190
Why?
Renal Insufficiency, Chronic
5
2016
349
1.170
Why?
Chemical and Drug Induced Liver Injury
3
2020
69
1.160
Why?
Genotype
22
2023
1853
1.160
Why?
Waiting Lists
6
2017
175
1.150
Why?
Donor Selection
2
2021
68
1.090
Why?
United States
29
2022
6674
1.090
Why?
Drug Therapy, Combination
20
2023
895
1.070
Why?
Patient Selection
7
2020
686
1.060
Why?
Amino Acids, Branched-Chain
5
2011
7
1.030
Why?
Risk Assessment
14
2021
2261
1.020
Why?
Lipase
3
2013
22
1.010
Why?
Heterocyclic Compounds, 4 or More Rings
4
2016
16
0.990
Why?
Carbamates
4
2016
19
0.980
Why?
Tissue and Organ Procurement
4
2019
311
0.950
Why?
Receptors, Cytoplasmic and Nuclear
2
2021
122
0.930
Why?
Prevalence
17
2017
1240
0.920
Why?
Nutritional Status
4
2013
83
0.910
Why?
Glomerular Filtration Rate
4
2014
385
0.900
Why?
Viral Load
12
2021
150
0.900
Why?
Metabolic Diseases
1
2023
48
0.890
Why?
Proportional Hazards Models
13
2021
860
0.890
Why?
Mycophenolic Acid
4
2013
87
0.860
Why?
Hepatocytes
9
2022
127
0.860
Why?
Hepatitis B, Chronic
2
2020
32
0.850
Why?
Diabetes Mellitus
7
2022
805
0.850
Why?
Fatty Liver, Alcoholic
3
2016
7
0.840
Why?
Adipokines
2
2014
19
0.840
Why?
Cholestasis, Intrahepatic
3
2015
17
0.830
Why?
Polymorphism, Single Nucleotide
7
2015
2357
0.830
Why?
Metformin
2
2023
128
0.820
Why?
Time Factors
19
2021
5215
0.820
Why?
Food-Drug Interactions
1
2021
18
0.790
Why?
Living Donors
6
2021
339
0.790
Why?
Prospective Studies
24
2021
4212
0.790
Why?
Keratan Sulfate
2
2012
6
0.790
Why?
Biopsy
20
2024
1163
0.780
Why?
Chondroitin Sulfate Proteoglycans
2
2012
38
0.780
Why?
Weight Gain
3
2020
123
0.760
Why?
Interferons
10
2014
133
0.760
Why?
Tenofovir
1
2020
7
0.760
Why?
Drug Compounding
1
2021
78
0.740
Why?
Disease Progression
13
2018
1534
0.740
Why?
Everolimus
2
2017
40
0.730
Why?
Aged
47
2019
18407
0.730
Why?
Polyethylene Glycols
7
2015
364
0.730
Why?
Alanine
1
2020
85
0.730
Why?
Dehydroepiandrosterone
2
2011
51
0.720
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
3
2023
378
0.720
Why?
Multivariate Analysis
10
2015
999
0.710
Why?
Delivery of Health Care, Integrated
1
2020
57
0.700
Why?
Bariatric Surgery
3
2019
194
0.690
Why?
Transplant Recipients
3
2021
122
0.690
Why?
Dietary Supplements
5
2012
128
0.690
Why?
Membrane Proteins
4
2013
1201
0.680
Why?
Obesity, Morbid
4
2018
225
0.660
Why?
Diabetes Mellitus, Type 1
6
2021
568
0.650
Why?
Follow-Up Studies
20
2021
3639
0.650
Why?
Elasticity Imaging Techniques
4
2018
59
0.640
Why?
Health Care Costs
1
2020
238
0.630
Why?
Global Health
2
2017
193
0.630
Why?
Fibroblast Growth Factors
2
2018
81
0.630
Why?
Adiponectin
3
2014
24
0.610
Why?
Chemoembolization, Therapeutic
2
2015
36
0.590
Why?
Hepatitis
3
2024
35
0.580
Why?
Oligopeptides
3
2014
180
0.580
Why?
Healthcare Disparities
1
2021
372
0.570
Why?
Population Surveillance
1
2018
219
0.570
Why?
Fluorenes
2
2016
8
0.560
Why?
Recombinant Proteins
10
2015
1018
0.550
Why?
Fatty Acids, Monounsaturated
2
2013
14
0.550
Why?
Insulin
10
2022
1160
0.540
Why?
Practice Patterns, Physicians'
1
2021
584
0.540
Why?
Enzyme-Linked Immunosorbent Assay
3
2014
378
0.520
Why?
Diet, High-Fat
2
2017
114
0.510
Why?
Benzimidazoles
2
2016
140
0.510
Why?
Biomarkers
10
2018
1722
0.510
Why?
Proline
2
2013
57
0.510
Why?
Apolipoproteins E
1
2015
129
0.510
Why?
Medically Uninsured
1
2015
58
0.510
Why?
Cholestasis
2
2017
47
0.500
Why?
Hepatic Encephalopathy
4
2023
42
0.500
Why?
Body Mass Index
9
2018
768
0.490
Why?
Survival Rate
12
2021
1864
0.490
Why?
Transplantation, Homologous
9
2021
996
0.480
Why?
Sarcopenia
1
2014
13
0.480
Why?
Insurance Coverage
1
2015
117
0.480
Why?
Liver Cirrhosis, Experimental
2
2016
7
0.480
Why?
Insurance, Health
1
2015
160
0.470
Why?
Gastroenterology
2
2021
140
0.470
Why?
Decision Support Techniques
1
2015
160
0.470
Why?
Nephrons
1
2013
18
0.470
Why?
Imidazoles
3
2019
162
0.460
Why?
Protease Inhibitors
1
2013
72
0.460
Why?
Diabetes Mellitus, Type 2
1
2023
1374
0.460
Why?
Prognosis
15
2021
3681
0.460
Why?
Lipogenesis
1
2013
22
0.450
Why?
Gastric Bypass
2
2012
110
0.450
Why?
Kaplan-Meier Estimate
7
2019
861
0.450
Why?
Severity of Illness Index
14
2019
1804
0.450
Why?
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
1
2013
54
0.440
Why?
Registries
6
2019
703
0.440
Why?
Steroids
1
2013
176
0.430
Why?
Proteomics
2
2011
212
0.430
Why?
Proteins
5
2001
777
0.420
Why?
Renal Insufficiency
4
2018
114
0.410
Why?
Drug Interactions
4
2019
248
0.410
Why?
Patient Reported Outcome Measures
3
2018
164
0.410
Why?
Cytochrome P-450 Enzyme Inhibitors
1
2011
10
0.410
Why?
Cohort Studies
10
2020
2765
0.410
Why?
Transplantation
2
2011
39
0.400
Why?
Hepatitis, Alcoholic
3
2020
19
0.400
Why?
Asia
3
2020
95
0.400
Why?
Health Services Accessibility
1
2015
394
0.400
Why?
Growth Hormone
1
2011
97
0.400
Why?
Retrospective Studies
21
2022
8476
0.400
Why?
Biliopancreatic Diversion
1
2011
4
0.400
Why?
Neutrons
1
2011
58
0.390
Why?
Radiation Protection
1
2011
25
0.390
Why?
Aging
1
2015
693
0.390
Why?
Gastroplasty
1
2011
21
0.390
Why?
Troponin I
1
2011
27
0.380
Why?
C-Reactive Protein
4
2014
190
0.380
Why?
Troponin
1
2010
24
0.370
Why?
Drug Resistance, Viral
4
2020
51
0.370
Why?
Case-Control Studies
7
2020
1809
0.370
Why?
Alleles
2
2013
1129
0.370
Why?
Maternal Nutritional Physiological Phenomena
1
2009
3
0.360
Why?
Radiation Dosage
1
2011
225
0.360
Why?
Drug Administration Schedule
8
2017
915
0.360
Why?
Amino Acids
7
2023
252
0.360
Why?
Kidney
2
2013
1245
0.360
Why?
Primary Graft Dysfunction
1
2009
27
0.350
Why?
Nutrition Surveys
3
2015
114
0.350
Why?
Kidney Diseases
1
2013
416
0.350
Why?
Kidney Transplantation
5
2019
849
0.350
Why?
Leucine
7
2001
67
0.350
Why?
Dose-Response Relationship, Drug
7
2024
1960
0.350
Why?
Fatty Acid-Binding Proteins
1
2009
26
0.340
Why?
Blood Glucose
7
2017
872
0.340
Why?
Hyperlipidemias
1
2009
95
0.340
Why?
Reoperation
6
2012
593
0.340
Why?
Long-Term Care
1
2009
61
0.340
Why?
Dietary Fats
1
2009
135
0.340
Why?
Apolipoproteins
2
2014
38
0.340
Why?
Practice Guidelines as Topic
4
2020
1037
0.330
Why?
Consensus
3
2019
336
0.330
Why?
Double-Blind Method
7
2024
1824
0.320
Why?
Health Care Reform
1
2009
90
0.320
Why?
Nuclear Proteins
1
2013
705
0.320
Why?
Liver Cirrhosis, Alcoholic
3
2013
23
0.320
Why?
Polymorphism, Genetic
1
2012
819
0.310
Why?
Antibodies
1
2010
352
0.310
Why?
Virus Replication
3
2006
319
0.310
Why?
Genetic Variation
3
2013
1351
0.300
Why?
Glucagon
2
1998
111
0.300
Why?
Immunoglobulins
4
2013
148
0.300
Why?
Animals
23
2024
26706
0.300
Why?
Survival Analysis
8
2014
1540
0.300
Why?
Secondary Prevention
5
2007
162
0.300
Why?
Benzamides
2
2018
229
0.300
Why?
Age Factors
7
2011
1849
0.290
Why?
Fibrosis
6
2023
204
0.290
Why?
Hypoglycemic Agents
4
2016
378
0.290
Why?
Randomized Controlled Trials as Topic
6
2021
864
0.290
Why?
Diabetes Complications
4
2021
207
0.290
Why?
Protein Biosynthesis
4
2002
382
0.280
Why?
Adolescent
11
2018
8988
0.280
Why?
Incidence
9
2019
1578
0.280
Why?
Leptin
3
2014
104
0.280
Why?
Alkaline Phosphatase
1
2006
132
0.280
Why?
Pyridines
2
2018
310
0.280
Why?
Databases, Factual
4
2021
816
0.270
Why?
Calcineurin Inhibitors
3
2015
55
0.270
Why?
Cause of Death
4
2016
277
0.270
Why?
Logistic Models
2
2012
1185
0.270
Why?
Transcription Factors
2
2013
1580
0.270
Why?
Young Adult
9
2021
5977
0.270
Why?
Inflammation Mediators
2
2017
155
0.270
Why?
Acute Kidney Injury
1
2009
296
0.270
Why?
Heart Transplantation
3
2021
705
0.260
Why?
Regression Analysis
5
2021
596
0.260
Why?
Apoptosis Regulatory Proteins
3
2011
199
0.260
Why?
Hypertension, Portal
2
2017
47
0.250
Why?
Preoperative Care
3
2017
397
0.250
Why?
Antibodies, Monoclonal, Humanized
5
2018
931
0.250
Why?
Alanine Transaminase
3
2012
73
0.250
Why?
Postoperative Period
4
2016
302
0.250
Why?
Body Weight
3
2023
458
0.250
Why?
Hepatitis, Viral, Human
3
2000
25
0.250
Why?
Predictive Value of Tests
5
2013
1672
0.240
Why?
Pyridazines
1
2024
22
0.240
Why?
Oligonucleotide Array Sequence Analysis
2
2003
691
0.240
Why?
Uracil
1
2024
72
0.230
Why?
Mice
12
2024
11439
0.230
Why?
Lactulose
1
2023
20
0.230
Why?
Biliary Tract
1
2003
13
0.230
Why?
Biliary Atresia
1
2003
22
0.230
Why?
Nutritional Support
1
2003
17
0.230
Why?
Sensitivity and Specificity
7
2013
1991
0.230
Why?
Hormones
2
2002
141
0.220
Why?
Combined Modality Therapy
2
2023
1686
0.220
Why?
Malnutrition
2
2013
34
0.220
Why?
MicroRNAs
2
2022
535
0.220
Why?
Minnesota
2
2013
46
0.220
Why?
Palmitates
3
2011
18
0.210
Why?
Proto-Oncogene Proteins
3
2011
645
0.210
Why?
Immunoglobulin G
3
2011
457
0.210
Why?
Organ Preservation Solutions
1
2022
28
0.210
Why?
Adipocytes
1
2023
155
0.210
Why?
DNA Virus Infections
2
1999
6
0.210
Why?
Blood Donors
2
2000
26
0.210
Why?
Mice, Inbred C57BL
5
2017
3111
0.210
Why?
Child
7
2017
6933
0.210
Why?
Hepatitis B
2
2019
74
0.210
Why?
Pregnancy
3
2015
2901
0.200
Why?
Administration, Oral
3
2016
683
0.200
Why?
Neoplasm Recurrence, Local
3
2018
1313
0.200
Why?
Disease Models, Animal
4
2023
2243
0.200
Why?
Flaviviridae
2
1999
3
0.200
Why?
Resistin
2
2014
14
0.200
Why?
Capsules
1
2021
38
0.200
Why?
Diet, Mediterranean
1
2021
6
0.200
Why?
MAP Kinase Kinase Kinase 5
2
2018
5
0.200
Why?
Lumican
2
2012
2
0.200
Why?
Brain Death
1
2022
69
0.200
Why?
Cytomegalovirus Infections
1
2002
144
0.200
Why?
Diet
2
2016
443
0.200
Why?
Polymerase Chain Reaction
6
2009
930
0.200
Why?
Cholesterol
1
2023
356
0.200
Why?
Risk
3
2009
674
0.190
Why?
Vitamin E
3
2016
35
0.190
Why?
Gene Expression
3
2011
1286
0.190
Why?
Apolipoprotein B-100
3
2014
12
0.190
Why?
Healthy Volunteers
1
2021
143
0.190
Why?
Sulfatases
1
2020
4
0.190
Why?
ROC Curve
4
2018
752
0.190
Why?
Collagen
4
2018
273
0.190
Why?
Nasturtium
1
2020
4
0.190
Why?
Fasciola hepatica
1
2020
5
0.190
Why?
Antibodies, Helminth
1
2020
11
0.190
Why?
Fascioliasis
1
2020
6
0.190
Why?
Dyspepsia
1
2020
10
0.190
Why?
Cross-Over Studies
1
2021
399
0.180
Why?
Cross-Sectional Studies
3
2023
1618
0.180
Why?
CCR5 Receptor Antagonists
1
2019
2
0.180
Why?
Sulfoxides
1
2019
6
0.180
Why?
Benzothiazoles
1
2019
17
0.180
Why?
Fibrinogen
3
2013
56
0.180
Why?
Tablets
1
2021
118
0.180
Why?
Comorbidity
3
2016
945
0.180
Why?
Eosinophilia
1
2020
84
0.180
Why?
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
2
2010
5
0.170
Why?
Aged, 80 and over
8
2016
6511
0.170
Why?
Isoxazoles
1
2019
77
0.170
Why?
Cohort Effect
1
2019
6
0.170
Why?
Multiple Organ Failure
1
2019
53
0.170
Why?
Basal Metabolism
1
1998
20
0.170
Why?
Islets of Langerhans Transplantation
1
2021
225
0.170
Why?
Isobutyrates
1
2018
1
0.170
Why?
Biological Products
1
2021
143
0.170
Why?
Oxazoles
1
2018
19
0.170
Why?
Acetyl-CoA Carboxylase
1
2018
24
0.160
Why?
Signal Transduction
4
2017
3267
0.160
Why?
Obesity Management
1
2018
1
0.160
Why?
Energy Metabolism
2
2017
272
0.160
Why?
Acute-On-Chronic Liver Failure
1
2018
5
0.160
Why?
Reference Values
3
2008
673
0.160
Why?
Aging, Premature
1
2018
7
0.160
Why?
Magnetic Resonance Imaging
4
2020
3366
0.160
Why?
Patient Care Management
1
2018
31
0.160
Why?
Drug Combinations
2
2015
224
0.160
Why?
Seroepidemiologic Studies
2
2015
55
0.160
Why?
Heart Defects, Congenital
1
2021
360
0.160
Why?
Publishing
2
2009
90
0.160
Why?
Nutrition Assessment
2
2012
21
0.160
Why?
Intestine, Small
1
2000
302
0.150
Why?
Internal Medicine
1
2021
349
0.150
Why?
Portal Pressure
1
2017
3
0.150
Why?
Glycosylation
1
2017
129
0.150
Why?
Sustained Virologic Response
4
2018
8
0.150
Why?
Hepatic Veins
1
2017
27
0.150
Why?
Mitochondria, Liver
1
2017
27
0.150
Why?
Hemoglobins
1
2017
180
0.150
Why?
Myosin Heavy Chains
1
1997
92
0.150
Why?
Cyclosporine
2
2011
236
0.150
Why?
Cholangitis, Sclerosing
3
2005
52
0.150
Why?
Apoptosis
4
2011
1689
0.150
Why?
Protein-Energy Malnutrition
1
1996
5
0.150
Why?
Curriculum
1
2021
542
0.150
Why?
Pilot Projects
2
2014
840
0.150
Why?
Adiposity
1
2017
70
0.140
Why?
Gallbladder Neoplasms
1
2016
22
0.140
Why?
Protein Synthesis Inhibitors
1
1996
36
0.140
Why?
Radiotherapy Dosage
1
2017
468
0.140
Why?
Immunocompromised Host
2
2015
140
0.140
Why?
Radiotherapy Planning, Computer-Assisted
1
2017
176
0.140
Why?
Students, Medical
1
2021
385
0.140
Why?
Protein Kinase Inhibitors
2
2017
589
0.140
Why?
Mass Screening
3
2017
619
0.140
Why?
Radiotherapy, Intensity-Modulated
1
2017
173
0.140
Why?
Lysophosphatidylcholines
1
2016
18
0.140
Why?
Antibodies, Monoclonal
3
2010
1380
0.140
Why?
Kidney Failure, Chronic
2
2016
509
0.140
Why?
Organ Size
1
2017
363
0.140
Why?
Transplants
1
2016
40
0.140
Why?
Kinetics
5
2014
1513
0.140
Why?
Internationality
1
2016
69
0.140
Why?
Palmitic Acid
1
2016
27
0.140
Why?
Postoperative Care
1
2017
221
0.140
Why?
Viral Nonstructural Proteins
2
2015
37
0.140
Why?
Cholangiocarcinoma
1
2016
66
0.140
Why?
Hepatitis E virus
1
2015
6
0.140
Why?
Laparoscopy
2
2014
754
0.140
Why?
Bile Duct Neoplasms
1
2016
79
0.130
Why?
Pyrimidines
1
2018
370
0.130
Why?
Lipids
1
2017
270
0.130
Why?
Biomarkers, Tumor
2
2018
1464
0.130
Why?
Compassionate Use Trials
1
2015
8
0.130
Why?
Muscle, Skeletal
2
2001
450
0.130
Why?
Organ Transplantation
2
2017
265
0.130
Why?
Species Specificity
1
2017
678
0.130
Why?
Extracellular Vesicles
1
2016
42
0.130
Why?
Immunohistochemistry
3
2009
1759
0.130
Why?
New Zealand
1
2014
22
0.130
Why?
Spain
1
2014
33
0.130
Why?
Uterine Cervical Neoplasms
1
2017
275
0.130
Why?
Antioxidants
1
2016
223
0.130
Why?
Monocytes
1
2016
216
0.130
Why?
Alcoholism
1
2016
172
0.130
Why?
Intestinal Mucosa
1
2000
797
0.130
Why?
Family
1
2016
311
0.130
Why?
Dyslipidemias
2
2020
109
0.120
Why?
Metalloendopeptidases
1
2014
45
0.120
Why?
Allosteric Regulation
1
2014
68
0.120
Why?
Killer Cells, Natural
1
2016
267
0.120
Why?
Pedigree
1
2016
966
0.120
Why?
Radiosurgery
1
2017
272
0.120
Why?
Adenocarcinoma
3
2016
1169
0.120
Why?
Early Detection of Cancer
1
2018
395
0.120
Why?
Arteries
1
2015
177
0.120
Why?
Bacterial Infections
1
2015
183
0.120
Why?
Antibodies, Neutralizing
1
2014
116
0.120
Why?
Interviews as Topic
1
2015
319
0.120
Why?
Endoscopy
2
2014
332
0.120
Why?
Hepatectomy
3
2019
166
0.120
Why?
Ascites
2
2018
56
0.120
Why?
Epigenesis, Genetic
1
2018
481
0.120
Why?
Glucose
3
2022
638
0.120
Why?
DNA, Viral
4
2019
265
0.120
Why?
Tissue and Organ Harvesting
1
2014
79
0.120
Why?
Probability
3
2007
354
0.110
Why?
Substance Abuse, Intravenous
1
2013
54
0.110
Why?
Mesocricetus
2
2023
107
0.110
Why?
Social Class
1
2013
128
0.110
Why?
DNA Methylation
1
2018
630
0.110
Why?
Hypertension
3
2010
1142
0.110
Why?
Hypoxia-Ischemia, Brain
1
2013
52
0.110
Why?
Emigrants and Immigrants
1
2013
44
0.110
Why?
Educational Status
1
2013
190
0.110
Why?
Nutrition Disorders
1
2012
16
0.110
Why?
Carbon Tetrachloride
1
2012
7
0.110
Why?
Sound
1
2013
26
0.110
Why?
Aneurysm, False
1
2013
54
0.110
Why?
Algorithms
2
2020
1830
0.110
Why?
Noise
1
2013
27
0.110
Why?
Hepatopulmonary Syndrome
1
2012
4
0.110
Why?
Intestines
1
2016
411
0.110
Why?
Hepatic Artery
1
2013
82
0.110
Why?
Lipid Metabolism
2
2004
197
0.110
Why?
Nutrition Therapy
1
2012
11
0.110
Why?
Animal Husbandry
1
2013
25
0.110
Why?
Carbon Isotopes
4
2001
76
0.110
Why?
Liver Circulation
1
2012
30
0.110
Why?
Histocytochemistry
1
2012
130
0.110
Why?
Protein Structure, Tertiary
1
2014
738
0.110
Why?
Plant Lectins
2
2015
11
0.110
Why?
Guanine
1
2013
208
0.110
Why?
Pulmonary Circulation
1
2012
86
0.110
Why?
Methylprednisolone
2
2003
66
0.110
Why?
Phenotype
3
2016
2389
0.110
Why?
Cytomegalovirus
2
2002
76
0.110
Why?
Pressure
1
2013
165
0.110
Why?
Cricetinae
2
2023
560
0.110
Why?
alpha-Fetoproteins
2
2015
45
0.110
Why?
Transforming Growth Factor beta1
1
2012
87
0.110
Why?
Propensity Score
1
2012
136
0.100
Why?
Statistics, Nonparametric
1
2012
308
0.100
Why?
Occupational Exposure
1
2013
79
0.100
Why?
Clinical Trials, Phase II as Topic
3
2019
176
0.100
Why?
Internship and Residency
1
2021
1010
0.100
Why?
Nephrectomy
1
2014
294
0.100
Why?
Isoquinolines
1
2012
72
0.100
Why?
Sex Factors
2
2013
1053
0.100
Why?
Complement C4
1
2011
10
0.100
Why?
PPAR gamma
1
2011
66
0.100
Why?
Enzyme Inhibitors
1
2014
639
0.100
Why?
Boron
1
2011
3
0.100
Why?
Polyethylene
1
2011
8
0.100
Why?
Unfolded Protein Response
1
2011
39
0.100
Why?
Disease-Free Survival
2
2006
1204
0.100
Why?
Particle Accelerators
1
2011
16
0.100
Why?
Up-Regulation
2
2011
717
0.100
Why?
Treatment Failure
3
2015
286
0.100
Why?
Photons
1
2011
46
0.100
Why?
Catheter Ablation
1
2013
233
0.100
Why?
Genetic Predisposition to Disease
3
2016
2272
0.100
Why?
Aquaporin 1
1
2010
5
0.090
Why?
Alcoholics
1
2010
1
0.090
Why?
Platelet-Derived Growth Factor
1
2010
67
0.090
Why?
Health Knowledge, Attitudes, Practice
1
2015
508
0.090
Why?
Child, Preschool
3
2012
3612
0.090
Why?
Adrenal Cortex Hormones
1
2011
261
0.090
Why?
Antidepressive Agents
1
2010
106
0.090
Why?
Interferon-gamma
1
2012
445
0.090
Why?
Glucocorticoids
2
2003
350
0.090
Why?
Clinical Trials as Topic
2
2018
1169
0.090
Why?
Cell Movement
2
2010
762
0.090
Why?
Sulfonamides
1
2012
300
0.090
Why?
Blood Group Incompatibility
1
2009
18
0.090
Why?
Mitogen-Activated Protein Kinase 8
1
2009
24
0.090
Why?
Heart Failure
1
2019
1207
0.090
Why?
Hepatitis B Surface Antigens
2
2013
24
0.090
Why?
Depressive Disorder
1
2010
218
0.090
Why?
ABO Blood-Group System
1
2009
62
0.080
Why?
Prediabetic State
1
2009
39
0.080
Why?
Biopsy, Needle
2
2007
234
0.080
Why?
Hemodynamics
1
2012
713
0.080
Why?
Mitochondria
2
2003
536
0.080
Why?
Weight Loss
3
2018
229
0.080
Why?
Tandem Mass Spectrometry
1
2009
103
0.080
Why?
Inflammation
1
2014
926
0.080
Why?
Hypertension, Pulmonary
1
2012
347
0.080
Why?
Dehydroepiandrosterone Sulfate
1
2008
16
0.080
Why?
Exercise
2
2018
315
0.080
Why?
Transforming Growth Factor beta
1
2010
303
0.080
Why?
Evidence-Based Medicine
1
2011
429
0.080
Why?
Contraindications
1
2008
72
0.080
Why?
Gene Regulatory Networks
1
2010
297
0.080
Why?
Protein Precursors
2
2015
143
0.080
Why?
Endothelium, Vascular
1
2010
437
0.080
Why?
Neovascularization, Pathologic
1
2010
356
0.080
Why?
Somatostatin
2
1998
55
0.080
Why?
Cell Line
1
2012
2476
0.080
Why?
Periodicals as Topic
1
2009
168
0.080
Why?
Macrophages
2
2024
560
0.070
Why?
Hepatitis B virus
2
2019
43
0.070
Why?
Coinfection
2
2017
58
0.070
Why?
Longitudinal Studies
1
2010
1019
0.070
Why?
Cell Proliferation
1
2012
1596
0.070
Why?
RNA, Messenger
2
2010
1988
0.070
Why?
Liver Function Tests
1
2006
93
0.070
Why?
Diffusion Magnetic Resonance Imaging
2
2022
294
0.070
Why?
Cell Line, Tumor
4
2016
2427
0.070
Why?
Safety
2
2007
152
0.070
Why?
Length of Stay
3
2014
704
0.070
Why?
Japan
1
2006
307
0.070
Why?
Apolipoproteins B
2
2002
38
0.070
Why?
Hepatitis, Autoimmune
2
2005
20
0.070
Why?
Neoplasm Invasiveness
1
2007
552
0.060
Why?
Hepatitis C Antibodies
2
2002
8
0.060
Why?
Hypophosphatemia
1
2004
8
0.060
Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
2005
57
0.060
Why?
Temperance
1
2004
7
0.060
Why?
Diet, Reducing
1
2004
31
0.060
Why?
RNA, Small Interfering
2
2020
547
0.060
Why?
Receptor for Advanced Glycation End Products
1
2024
17
0.060
Why?
Cystic Fibrosis
1
2005
112
0.060
Why?
Perioperative Care
1
2006
162
0.060
Why?
Likelihood Functions
1
2004
251
0.060
Why?
Immunization, Passive
1
2003
72
0.060
Why?
Thyroid Hormone Receptors beta
1
2024
81
0.060
Why?
DNA-Directed DNA Polymerase
1
2003
25
0.060
Why?
DNA Mutational Analysis
1
2005
526
0.060
Why?
T-Lymphocytes
1
2010
1200
0.060
Why?
Spike Glycoprotein, Coronavirus
1
2023
41
0.060
Why?
Patient Acuity
1
2023
33
0.060
Why?
Viral Interference
1
2002
4
0.060
Why?
Immunocompetence
1
2002
27
0.050
Why?
Age Distribution
1
2003
204
0.050
Why?
Disease Management
2
2017
328
0.050
Why?
Skin Neoplasms
1
2007
546
0.050
Why?
Raffinose
1
2022
24
0.050
Why?
Diacylglycerol O-Acyltransferase
1
2022
4
0.050
Why?
Potassium Chloride
1
2022
87
0.050
Why?
Cells, Cultured
3
2014
2839
0.050
Why?
Physician Assistants
1
2002
19
0.050
Why?
BCG Vaccine
1
2002
31
0.050
Why?
Neoplasms
2
2014
2898
0.050
Why?
Erythropoietin
1
2002
91
0.050
Why?
Glutathione
1
2022
104
0.050
Why?
Allopurinol
1
2022
80
0.050
Why?
Carcinoma in Situ
1
2002
53
0.050
Why?
Gene Expression Profiling
2
2010
1387
0.050
Why?
Caproates
2
2001
7
0.050
Why?
Clinical Protocols
1
2002
156
0.050
Why?
Microsatellite Repeats
1
2002
145
0.050
Why?
Organ Preservation
1
2022
83
0.050
Why?
Erythrocyte Transfusion
1
2002
60
0.050
Why?
RNA Interference
2
2016
370
0.050
Why?
Oxidative Stress
1
2004
448
0.050
Why?
Serum Albumin
1
2002
130
0.050
Why?
Anemia
1
2002
128
0.050
Why?
Adjuvants, Immunologic
1
2002
167
0.050
Why?
Mice, Knockout
2
2020
1944
0.050
Why?
Quality of Life
3
2018
1587
0.050
Why?
Bilirubin
1
2021
125
0.050
Why?
Cytoplasm
1
2001
282
0.050
Why?
Muscle Proteins
2
2001
133
0.050
Why?
Phenylalanine
2
2001
37
0.050
Why?
Fast Foods
1
2020
2
0.050
Why?
Cell Size
1
2000
66
0.050
Why?
Antiplatyhelmintic Agents
1
2020
6
0.050
Why?
Mice, 129 Strain
1
2020
55
0.050
Why?
Life Cycle Stages
1
2020
16
0.050
Why?
Anthropometry
1
2000
74
0.050
Why?
Costs and Cost Analysis
1
2021
153
0.050
Why?
Circoviridae Infections
1
2000
3
0.050
Why?
Creatinine
2
2013
339
0.050
Why?
Hand Strength
1
2000
51
0.050
Why?
Diet, Western
1
2020
37
0.050
Why?
Binding Sites
2
2014
1104
0.050
Why?
Sodium Bicarbonate
1
2000
10
0.050
Why?
Hepatitis B e Antigens
1
2019
8
0.050
Why?
Absorptiometry, Photon
1
2000
99
0.050
Why?
Career Choice
1
2021
141
0.040
Why?
bcl-2-Associated X Protein
2
2010
47
0.040
Why?
Receptors, CCR2
1
2019
35
0.040
Why?
Travel
1
2020
68
0.040
Why?
Hematuria
1
2000
48
0.040
Why?
Transplantation, Heterologous
1
2021
363
0.040
Why?
Ultrasonography
1
2002
692
0.040
Why?
Urologic Diseases
1
2000
45
0.040
Why?
Adenosine
1
2022
225
0.040
Why?
Educational Measurement
1
2021
226
0.040
Why?
Multicenter Studies as Topic
1
2019
159
0.040
Why?
Urologic Neoplasms
1
2000
77
0.040
Why?
Calorimetry, Indirect
1
1998
15
0.040
Why?
Artificial Intelligence
1
2022
295
0.040
Why?
Abdominal Pain
1
2020
136
0.040
Why?
Carnitine
1
2018
14
0.040
Why?
Down-Regulation
1
2020
508
0.040
Why?
Acute Disease
1
2000
827
0.040
Why?
Injections, Subcutaneous
1
2018
117
0.040
Why?
HIV Infections
2
2017
773
0.040
Why?
Chronic Disease
2
2003
972
0.040
Why?
Anti-Bacterial Agents
1
2023
747
0.040
Why?
Urinary Bladder Neoplasms
1
2002
383
0.040
Why?
Allografts
1
2019
172
0.040
Why?
Risk Adjustment
1
2018
39
0.040
Why?
Organs at Risk
1
2017
41
0.040
Why?
Datasets as Topic
1
2018
71
0.040
Why?
Immune Tolerance
1
2000
337
0.040
Why?
Oxidation-Reduction
1
1998
373
0.040
Why?
Tumor Suppressor Proteins
2
2010
279
0.040
Why?
Blood Transfusion
1
1998
157
0.040
Why?
CpG Islands
1
2018
152
0.040
Why?
Phosphorylation
2
2010
1106
0.040
Why?
Utah
1
2016
10
0.040
Why?
Bile Ducts, Extrahepatic
1
2016
12
0.040
Why?
Gene Frequency
2
2011
677
0.040
Why?
Lung
1
2023
1170
0.040
Why?
3-Hydroxybutyric Acid
1
1996
7
0.040
Why?
Linear Models
1
2018
421
0.040
Why?
Infusions, Intravenous
1
1997
429
0.040
Why?
Biliary Tract Neoplasms
1
2016
33
0.040
Why?
Models, Biological
2
2018
1752
0.040
Why?
Intention to Treat Analysis
1
2016
72
0.040
Why?
Hydroxybutyrates
1
1996
27
0.040
Why?
Bile Ducts, Intrahepatic
1
2016
70
0.040
Why?
Fatty Acids, Nonesterified
1
1996
70
0.040
Why?
Glycerol
1
1996
33
0.040
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2016
4
0.030
Why?
Parenteral Nutrition
1
1996
60
0.030
Why?
Clinical Trials, Phase III as Topic
1
2016
172
0.030
Why?
Catecholamines
1
1996
88
0.030
Why?
Societies, Scientific
1
2016
44
0.030
Why?
Diagnosis, Differential
1
2020
1564
0.030
Why?
Clinical Decision-Making
1
2018
257
0.030
Why?
Clinical Competence
1
2021
756
0.030
Why?
Mice, SCID
1
2016
254
0.030
Why?
Caspases
1
2016
155
0.030
Why?
Prothrombin
1
2015
18
0.030
Why?
Reproducibility of Results
2
2018
2704
0.030
Why?
Isoflurane
1
1995
64
0.030
Why?
Fluorescence Polarization
1
2014
9
0.030
Why?
Anesthetics, Inhalation
1
1995
95
0.030
Why?
Allosteric Site
1
2014
23
0.030
Why?
Dependovirus
1
2014
34
0.030
Why?
Biocatalysis
1
2014
51
0.030
Why?
Hydrocortisone
1
1996
301
0.030
Why?
Necrosis
1
2015
204
0.030
Why?
rho-Associated Kinases
1
2016
160
0.030
Why?
Catalytic Domain
1
2014
156
0.030
Why?
Iothalamic Acid
1
2013
11
0.030
Why?
Kidney Function Tests
1
2014
124
0.030
Why?
Cytokines
1
2018
781
0.030
Why?
Transfection
1
2016
898
0.030
Why?
Molecular Structure
1
2014
287
0.030
Why?
Pneumonia
1
2015
179
0.030
Why?
Lactates
1
2013
37
0.030
Why?
Substrate Specificity
1
2014
347
0.030
Why?
Models, Chemical
1
2014
178
0.030
Why?
Aspartic Acid
1
2013
64
0.030
Why?
HEK293 Cells
1
2016
617
0.030
Why?
Societies, Medical
1
2017
573
0.030
Why?
Clostridium Infections
1
2015
125
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2009
881
0.030
Why?
Decontamination
1
2013
9
0.030
Why?
Infant
2
1997
3048
0.030
Why?
Crystallography, X-Ray
1
2014
485
0.030
Why?
Mutation, Missense
1
2014
276
0.030
Why?
Rats, Sprague-Dawley
1
2016
1222
0.030
Why?
Equipment and Supplies
1
2013
30
0.030
Why?
Texas
1
2013
101
0.030
Why?
Sphincterotomy, Endoscopic
1
1992
9
0.030
Why?
Gallstones
1
1992
14
0.030
Why?
Environmental Monitoring
1
2013
71
0.030
Why?
Vascular Resistance
1
2012
102
0.030
Why?
Magnetic Resonance Spectroscopy
1
2013
315
0.030
Why?
Gastrectomy
1
2012
68
0.030
Why?
Inpatients
1
2015
298
0.030
Why?
Arterial Pressure
1
2012
38
0.030
Why?
Vasodilation
1
2012
96
0.030
Why?
Replicon
1
2012
8
0.030
Why?
Observer Variation
1
2013
602
0.030
Why?
Mice, Transgenic
1
2016
1557
0.030
Why?
Thiazolidinediones
1
2012
82
0.030
Why?
Keto Acids
2
2001
6
0.030
Why?
Swine, Miniature
2
2001
51
0.030
Why?
Odds Ratio
1
2013
679
0.030
Why?
Risk Reduction Behavior
1
2012
98
0.030
Why?
Sample Size
1
2012
130
0.030
Why?
Life Style
1
2012
189
0.020
Why?
3' Untranslated Regions
1
2011
92
0.020
Why?
Luciferases
1
2011
119
0.020
Why?
Radiography
1
2013
808
0.020
Why?
Chi-Square Distribution
1
2011
364
0.020
Why?
Infant, Newborn
2
2013
2380
0.020
Why?
Albumins
1
2011
133
0.020
Why?
Protein Binding
1
2014
1462
0.020
Why?
Osmosis
1
2010
6
0.020
Why?
Neuropilin-1
1
2010
15
0.020
Why?
Hepatic Stellate Cells
1
2010
10
0.020
Why?
Genes, Reporter
1
2011
271
0.020
Why?
Tomography, X-Ray Computed
2
2015
2585
0.020
Why?
Receptor, Platelet-Derived Growth Factor beta
1
2010
28
0.020
Why?
Regulatory Factor X Transcription Factors
1
2010
11
0.020
Why?
Transcription Factor CHOP
1
2010
15
0.020
Why?
X-Box Binding Protein 1
1
2010
17
0.020
Why?
Rodentia
1
2010
42
0.020
Why?
Immunoprecipitation
1
2010
135
0.020
Why?
Bcl-2-Like Protein 11
1
2010
22
0.020
Why?
Models, Molecular
1
2014
1286
0.020
Why?
Cell Membrane Permeability
1
2010
119
0.020
Why?
Swine
2
2001
559
0.020
Why?
Anthracenes
1
2009
16
0.020
Why?
JNK Mitogen-Activated Protein Kinases
1
2010
113
0.020
Why?
Electrocardiography
1
2012
478
0.020
Why?
Haplotypes
1
2011
642
0.020
Why?
Intercellular Signaling Peptides and Proteins
1
2010
180
0.020
Why?
Alcohol Drinking
1
2012
267
0.020
Why?
Altruism
1
2009
35
0.020
Why?
Molecular Targeted Therapy
1
2011
266
0.020
Why?
Immunoblotting
1
2009
268
0.020
Why?
Medication Adherence
1
2010
129
0.020
Why?
Extracellular Matrix
1
2010
235
0.020
Why?
Water
1
2010
277
0.020
Why?
Surveys and Questionnaires
1
2016
2502
0.020
Why?
Endoplasmic Reticulum
1
2010
250
0.020
Why?
Esophagus
1
1989
102
0.020
Why?
Rats
1
2014
4004
0.020
Why?
Stress, Physiological
1
2010
227
0.020
Why?
Microscopy, Fluorescence
1
2009
425
0.020
Why?
Delayed-Action Preparations
1
2007
116
0.020
Why?
Cell Membrane
1
2010
666
0.020
Why?
Transplantation Tolerance
1
2007
130
0.020
Why?
Base Sequence
2
2000
2335
0.020
Why?
Molecular Sequence Data
2
2000
3035
0.020
Why?
Liver Regeneration
1
2004
32
0.020
Why?
Referral and Consultation
1
2007
328
0.020
Why?
Statistics as Topic
1
2005
238
0.010
Why?
Phosphates
1
2004
160
0.010
Why?
DNA-Binding Proteins
1
2010
1214
0.010
Why?
Administration, Intravesical
1
2002
33
0.010
Why?
Actins
1
2005
451
0.010
Why?
RNA, Transfer, Leu
1
2001
11
0.010
Why?
Sarcoplasmic Reticulum
1
2001
24
0.010
Why?
Body Fluids
1
2001
36
0.010
Why?
Nitrogen Isotopes
1
2001
14
0.010
Why?
HLA-DR3 Antigen
1
2001
1
0.010
Why?
HLA-DR4 Antigen
1
2001
3
0.010
Why?
RNA, Transfer, Amino Acyl
1
2001
11
0.010
Why?
DNA, Neoplasm
1
2002
265
0.010
Why?
Carcinoma, Transitional Cell
1
2002
164
0.010
Why?
Circovirus
1
2000
6
0.010
Why?
Models, Animal
1
2001
264
0.010
Why?
DNA Viruses
1
1999
16
0.010
Why?
Pain
1
2002
390
0.010
Why?
RNA, Transfer
1
2001
151
0.010
Why?
Cholangiography
1
1999
41
0.010
Why?
Serologic Tests
1
1999
41
0.010
Why?
Myocardium
1
2001
550
0.010
Why?
Heart
1
2001
557
0.010
Why?
Survivors
1
1999
227
0.010
Why?
Forecasting
1
1999
305
0.010
Why?
Nuclear Reactors
1
1993
8
0.010
Why?
England
1
1993
41
0.010
Why?
Poisson Distribution
1
1993
51
0.010
Why?
Cholangiopancreatography, Endoscopic Retrograde
1
1992
62
0.010
Why?
Mutation
1
2003
3977
0.010
Why?
Lymphoma, Non-Hodgkin
1
1993
261
0.010
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
1993
375
0.010
Why?
Morbidity
1
1989
148
0.010
Why?
Mortality
1
1989
150
0.000
Why?
Anastomosis, Surgical
1
1989
267
0.000
Why?
Brain Neoplasms
1
1993
763
0.000
Why?
Esophageal Neoplasms
1
1989
322
0.000
Why?
Carcinoma, Squamous Cell
1
1989
1077
0.000
Why?
Charlton's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (760)
Explore
_
Co-Authors (30)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_